Bolt Biotherapeutics (BOLT) Insider Trading & Ownership → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free BOLT Stock Alerts $0.78 -0.01 (-1.54%) (As of 11:20 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Bolt Biotherapeutics (NASDAQ:BOLT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$11,233.22Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$125,191.15 Get BOLT Insider Trade Alerts Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BOLT Insider Buying and Selling by Quarter Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Bolt Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/12/2023William P QuinnCFOBuy7,500$0.95$7,125.00 12/6/2023William P QuinnCFOBuy2,500$0.78$1,950.00 11/29/2023Edgar EnglemanDirectorSell25,805$0.91$23,482.55 11/20/2023Edgar EnglemanDirectorSell31,257$0.92$28,756.44 11/20/2023Vivo Capital Viii, LlcMajor ShareholderSell54,700$0.92$50,324.00 11/16/2023Edgar EnglemanDirectorSell8,571$0.96$8,228.16 11/16/2023Vivo Capital Viii, LlcMajor ShareholderSell15,000$0.96$14,400.00 6/6/2023William P QuinnCFOBuy1,829$1.18$2,158.22 (Data available from 1/1/2013 forward) BOLT Insider Trading Activity - Frequently Asked Questions Who is on Bolt Biotherapeutics's Insider Roster? The list of insiders at Bolt Biotherapeutics includes Edgar Engleman, Holdings A/S Novo, Vivo Capital Viii, Llc, and William P Quinn. Learn more on insiders at BOLT. What percentage of Bolt Biotherapeutics stock is owned by insiders? 30.90% of Bolt Biotherapeutics stock is owned by insiders. Learn more on BOLT's insider holdings. Which Bolt Biotherapeutics insiders have been buying company stock? The following insider purchased BOLT shares in the last 24 months: William P Quinn ($11,233.22). How much insider buying is happening at Bolt Biotherapeutics? Insiders have purchased a total of 11,829 BOLT shares in the last 24 months for a total of $11,233.22 bought. Which Bolt Biotherapeutics insiders have been selling company stock? The following insiders have sold BOLT shares in the last 24 months: Edgar Engleman ($60,467.15), Holdings A/S Novo ($1,600,000.00), and Vivo Capital Viii, Llc ($64,724.00). How much insider selling is happening at Bolt Biotherapeutics? Insiders have sold a total of 935,333 Bolt Biotherapeutics shares in the last 24 months for a total of $1,725,191.15 sold. More Insider Trading Tools from MarketBeat Related Companies: Fortress Biotech Insider Trades Regulus Therapeutics Insider Trades Rigel Pharmaceuticals Insider Trades Reviva Pharmaceuticals Insider Trades Clene Insider Trades Immuneering Insider Trades Reneo Pharmaceuticals Insider Trades Equillium Insider Trades Aadi Bioscience Insider Trades Nabriva Therapeutics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock Lately This page (NASDAQ:BOLT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.